The a2 Milk Company Limited (ACOPY) is a publicly traded company in the Consumer Defensive sector, operating within the Agricultural Farm Products industry. The company is headquartered in Auckland, New Zealand. The current CEO is David L. Bortolussi.
ACOPY has IPO date of 2019-05-21, 488 full-time employees, listed on the Other OTC, a market capitalization of $4.2B.
The a2 Milk Company Limited is a dairy products company incorporated in New Zealand that produces and sells milk and infant formula made from A2 protein type cattle. The company markets its fresh milk products under the a2 Milk brand and infant formula under the a2 Platinum brand across multiple regions including Australia, New Zealand, China, other Asian countries, and the United States. Founded in 2000 and headquartered in Auckland, New Zealand, the company has positioned itself as a specialist in A2 protein dairy products, distinguishing itself from conventional dairy manufacturers. The company operates through subsidiaries to manage its global distribution and market presence across key developed and emerging markets.